Chronic myeloid leukemia treatment intolerance imposes additional resource and economic burden on oncology practices in the United States
That is the title of a new paper out last week in Future Oncology with co-authors Kejal Jadhav, Cheryl Warren, Sabiha Quddus, Nadine Zawadzki, Daisy Yang, Andrea Damon,.
